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Autosomal-Dominant Calcium ATPase Disorders
Re´ka Szigeti1 and Richard Kellermayer2
Darier disease (DD) and Hailey–Hailey disease (HHD)
are the only known autosomal-dominant Ca2þ ATPase
disorders. Epidermal symptoms selectively occur in
the affected individuals, the precise reason for which
is still not fully understood. Here, we review the
clinical, epidermal, and molecular features of the two
genodermatoses. It is concluded that epidermal Ca2þ
regulation disturbances and epigenetic factors may
play an even more prominent role in the pathogenesis
of DD and HHD than earlier appreciated.
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INTRODUCTION
Major advancements have been made in our understanding
of skin disorders with epidermal cell adhesion defects around
the turn of the millennium. One such step was the
identification of pathogenic ATP2A2 mutations encoding
SERCA2 (sarco/endoplasmic reticulum Ca2þ -transport ATP-
ase isoform 2) in Darier- or Darier–White disease (DD, also
known as keratosis follicularis, OMIM#124200) (Sakuntabhai
et al., 1999b). Shortly after, two separate research groups
have identified ATP2C1 (the gene encoding the human
secretory pathway Ca2þ /Mn2þ ATPase (hSPCA1)) as the
pathogenic gene in Hailey–Hailey disease (HHD,
OMIM#169600), or chronic benign familial pemphigus (Hu
et al., 2000; Sudbrak et al., 2000). These observations
underscored the pivotal role of epidermal Ca2þ regulation
in promoting proper cell-to-cell adhesion. DD and HHD
represent the only known autosomal dominantly inherited
Ca2þ ATPase defects in humans. Except for a subpopulation
of DD patients – in whom psychiatric symptoms develop
likely as a result of neighboring gene co-segregation – only
epidermal symptoms occur. This peculiar feature of these
disorders is still not fully understood despite advancements in
elucidating their pathogenesis. Here, we focus on the most
recent literature and highlight the possible explanations for
the selective epidermal defects in DD and HHD.
CLINICAL AND HISTOLOGIC FEATURES OF
AUTOSOMAL-DOMINANT CA2þ ATPASE DISORDERS
Autosomal-dominant mutations of ATP2A2 lead to DD.
Acantholytic, dyskeratotic epidermal nevi appear to be
unilateral segmental presentations of DD (Sakuntabhai et al.,
2000; Reese et al., 2005) and acrokeratosis verruciformis of
Hopf is also allelic to DD (Dhitavat et al., 2003c). On the
other hand, autosomal mutations in ATP2C1 lead to HHD.
Both diseases selectively affect the skin, more precisely the
stratified squamous epithelium, as the occasional, uncommon
involvement of the mucosa has been noted in DD (Al Robaee
et al., 2004), more rarely in HHD (Heinze, 1979; Vaclavin-
kova and Neumann, 1982). Mood disorders have also been
described in association with DD, but current data suggest
that this is due to a susceptibility locus co-segregating with
ATP2A2 rather than pleiotropy (Green et al., 2005).
The incidence of the two disorders is similar,
1:25,000–1:100,000 (Svendsen and Albrectsen, 1959; Milj-
kovic et al., 2005) for DD and 1:50,000 for HHD (Burge,
1992). This is true for the onset and the triggering factors of
the symptoms also, as both skin defects present after age 10,
usually around puberty, but before the third to fourth decades
of life. Heat, sweating, mechanical trauma, infection, and
UVB exposure can cause the exacerbations. Remissions and
relapses characterize the course of the disorders (Burge,
1992; Burge and Wilkinson, 1992). As far as distribution and
the appearance of the rash, there may be considerable
differences, with DD usually affecting the seborrheic and
HHD the flexural areas. Greasy, warty papules, and plaques
characterize the rash of DD that are frequently malodorous.
Punctate keratoses of the palms and the soles with a central
depression are also pathognomic features. The nails are thin
with white lines and/or longitudinal ridges and tend to break
at the distal end (Zaias and Ackerman, 1973; Burge, 1994;
Cooper and Burge, 2003; Hovnanian, 2004). The morpho-
logy of HHD varies. Vesicular lesions, crusted erosions with
vesiculopustules, and small erythematous scaly plaques can
occur. Longitudinal white lines on the nails are also frequent
findings (Burge, 1992).
Penetrance is complete but expressivity varies significantly
in both disorders. No clear correlations have been established
between phenotype and genotype in either disease. The onset
around puberty and the fact that allergens and drugs can
exacerbate the symptoms argues that hormonal status and
epigenetic factors greatly influence the clinical appearance of
DD and HHD (Dhitavat et al., 2004; Foggia and Hovnanian,
2004; Sehgal and Srivastava, 2005).
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The most prominent common epidermal histologic feature
of DD and HHD is suprabasal acantholysis, resulting from
desmosomal disintegration. DD epidermis on light micro-
scopy also shows premature and abnormal keratinization
(dyskeratosis, hyperkeratosis), corps ronds (these structures
contain multiple lamellar bodies resembling apoptotic cells),
and eosinophilic dyskertotic cells (Burge and Schomberg,
1992). Electron microscopy reveals basal-cell vacuolization,
decreased lateral membrane desmosomes, separation of
tonofilaments from their insertion sites on the cell membrane,
and large circular aggregates around the nucleus (Caulfield
and Wilgram, 1963; Tada and Hashimoto, 1998). Histo-
pathology of HHD skin lesions shows a widespread loss
of cell-to-cell adhesion (acantholysis) in the suprabasal
layer of the epidermis. Ultrastructural studies demonstrate
perinuclear aggregation of keratin intermediate filaments,
which have retracted from the desmosomal plaques in the
acantholytic cells (Hashimoto et al., 1995; Metze et al.,
1996).
MOLECULAR ASPECTS OF AUTOSOMAL-DOMINANT
CA2þ ATPASE DISORDERS
Currently known Ca2þ ATPase-related human disorders
are Brody disease, type II diabetes mellitus, DD, and HHD.
Brody disease is an autosomal recessive myopathy where
considerable genetic heterogeneity has been detected.
However, a subset of patients carry mutations in both alleles
of ATP2A1, the gene encoding SERCA1 (Odermatt et al.,
1996). Polymorphisms in the SERCA3 gene (ATP2A3) have
been implicated to contribute to type II diabetes genetic
susceptibility (Varadi et al., 1999). Yet, it is only DD and
HHD that are related to dominant mutations in Ca2þ
ATPases.
ATP2A2
ATP2A2, the gene mutated in DD, is located in the
12q23–24.1 chromosomal region. The gene spans 76 kb with
21 exons. It encodes a 4.5 kb transcript that is alternatively
spliced into three variants ATP2A2a, ATP2A2b, and AT-
P2A2c, which are translated into SERCA2a, SERCA2b, and
SERCA2c, respectively (Gelebart et al., 2003). These proteins
belong to the SERCA subfamily of the P-type Ca2þ ATPase
family catalyzing the hydrolysis of ATP coupled with the
translocation of two cytoplasmic Ca2þ ions into the
endoplasmic reticulum (ER) lumen per cycle (Wuytack
et al., 2002). Based on the key architectural features of
SERCA1, the translated SERCA2a and SERCA2c proteins are
composed of three cytoplasmic domains and 10 hydrophobic
transmembrane helices (Xu et al., 2002). SERCA2b appears to
contain an additional transmembrane domain with the
extreme C terminus protruding into the ER lumen (Bayle
et al., 1995). Observations that among the variants, epider-
mal expression of SERCA2b is most preponderant and that
some pathogenic ATP2A2 mutations selectively affect
SERCA2b indicated that loss of isoform b expression only
is sufficient to cause DD (Ikeda et al., 2003; Dhitavat et al.,
2003b). This isoform has a higher affinity but a lower
transport capacity for Ca2þ than SERCA2a and SERCA1
(Dode et al., 2003).
More than 100 pathogenic ATP2A2 mutations, scattered
throughout the gene, have been reported to date. These affect
the Ca2þ transport activity and/or the expression level
of SERCA2b (Dode et al., 2003; Sato et al., 2004). Most
mutant SERCA2 display decreased expression and/or stability,
suggesting that haploinsufficiency is the common mechanism
for the dominant inheritance of DD. Yet, some findings
indicate that dimerization between SERCA2b proteins may
occur consequently leading to a dominant-negative mechan-
ism compounding haploinsufficiency (Ahn et al., 2003). This
may be the reason in part why some missense mutations
cause severe forms of DD (Sakuntabhai et al., 1999a).
ATP2C1
The ATP2C1 gene associated with HHD comprises 28 exons
in an approximately 30 kb segment of chromosome 3q21. It
encodes a 4.5 kb transcript that is alternatively spliced into
four variants, ATP2C1a–d (Hu et al., 2000; Sudbrak et al.,
2000; Ikeda et al., 2001; Dobson-Stone et al., 2002; Yokota
et al., 2002). ATP2C1d is the largest variant containing the
entire exons 27 and 28 (Fairclough et al., 2003). The isoforms
are translated into hSPCA1a–d, respectively. These proteins
belong to the SPCA subfamily of P-type ion motive ATPases.
SPCA pumps possess only one of the two high-affinity Ca2þ
binding sites characteristic of SERCA. However, these can
transport not only a single Ca2þ ion but also a Mn2þ ion per
cycle. Such characteristics separate SPCA from the P-type
SERCA and plasmamembrane Ca2þ pumps (Wuytack et al.,
2002, 2003). Recent observations indicate that hSPCA1c
is a rapidly degradable, non-functional protein. The other
isoforms appear to be expressed similarly, with hSPCA1d
transporting Ca2þ most effectively. Nevertheless, hSPCA1
isoforms are also high-affinity, low-capacity Ca2þ ATPases in
comparison to SERCA1 (Dode et al., 2005).
To date, more than 80 different ATP2C1 mutations have
been reported in HHD. Among these, 20% are nonsense
mutations, 19% are splice site mutations, 30% are frameshift
mutations leading to premature termination codons, 28%
are missense mutations, and B3% are in-frame deletions or
insertions (Foggia and Hovnanian, 2004; Missiaen et al.,
2004; Majore et al., 2005). The high number of mutations
leading to premature termination codons pointed to haplo-
insufficiency as the prevalent mechanism for the dominant
inheritance of HHD. Studies on missense mutations affecting
protein stability and function have shown that although
mutant ATP2C1 mRNA levels are normal, the level of the
defective protein is lower than that of the wild type despite
correct targeting to the Golgi. These observations lent further
support for haploinsufficiency as the primary mechanism
for the dominant inheritance of HHD (Fairclough et al.,
2003, 2004). Experiments in a yeast model system were
also consistent with this notion. Namely, overexpression of
mutant SPCA1 did not lead to the suppression of PMR1 (the
structural and functional homologue of SPCA1 in yeast)
function (Ton and Rao, 2004).
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Expression, regulation, and function of ATP2A2 and
ATP2C1. SERCA2b and hSPCA1 are most abundantly
expressed in keratinocytes and contribute to cellular Ca2þ
homeostasis most prominently in these cells (Sakuntabhai
et al., 1999b; Hu et al., 2000; Behne et al., 2003; Callewaert
et al., 2003; Van Baelen et al., 2003; Tavadia et al., 2004). An
increase in extracellular Ca2þ induces the transcription of
both ATP2A2 and ATP2C1 (Mayuzumi et al., 2005a). Ca2þ
appears to exert this effect on the latter gene by promoting the
nuclear accumulation of the transcription factor Sp1 that
binds to cis-enhancing elements of the ATP2C1 promoter.
This regulation was found to be absent in HHD keratinocytes
(Kawada et al., 2005). Nevertheless, extracellular Ca2þ
stimulation positively affects the amount of SPCA1 in HHD
keratinocytes compared to normal cells (Behne et al.,
2003). Similarly, the yeast homologue of hSPCA1, PMR1, is
positively regulated by Ca2þ both at the transcriptional and
translational level (Cunningham and Fink, 1996), suggesting
that Ca2þ -induced secretory pathway Ca2þ /Mn2þ ATPase
upregulation may be conserved throughout evolution. How-
ever, it should be noted that all the above observations have
been made in cultured keratinocytes and have not been
confirmed in vivo in the epidermis.
As opposed to Ca2þ , UVB irradiation (an exacerbating
factor for both DD and HHD) causes decreased ATP2A2 and
ATP2C1 transcription (Mayuzumi et al., 2005a). Drugs that
have proved useful in the treatment of these disorders inhibit
the transcriptional effects of UVB, indicating that even
anti-inflammatory medications may have a direct cellular
(beneficial) effect in these disorders (Mayuzumi et al.,
2005b). Observations in a yeast model system also support
this possibility (Szigeti and Kellermayer, 2004).
An earlier study showed that SERCA2b expression is
somewhat more prominent in the basal epidermis (Sheridan
et al., 2002). However, this has not been observed in other
experiments later (Tavadia et al., 2004). On the other hand,
the epidermal distribution of hSPCA1 has not been addressed
to date. Nevertheless, one would expect – based on the
positive regulatory effects of Ca2þ on ATP2A2 and ATP2C1
expression – that SERCA2b and hSPCA1 are most abundant
in the granular layer of the skin where Ca2þ levels are
the highest. The fact that the granular layer’s Ca2þ content
decreased in HHD indicates that this layer is affected
most severely with regard to total cellular calcium by the
haploinsufficiency of hSPCA1. The conflicting results on
epidermal SERCA2b distribution raise the possibility that the
reliability of immunochemistry may be hampered by epitope
masking through Ca2þ -dependent conformational changes
and dynamically altering protein–protein interactions in
the epidermal layers. Consequently, the epidermal expression
pattern of SERCA2b and hSPCA1 will have to be addressed by
methods other than immunochemistry in the future. How-
ever, irrespective of the expression pattern, it has been found
that the amount of SERCA2b is similar in the unaffected skin
of DD patients as in normal individuals and that the amount
of hSPCA1 in unaffected HHD skin is only mildly decreased.
On the contrary, the expression of both proteins significantly
decreases in the affected areas of the skin (Tavadia et al.,
2004; Porgpermdee et al., 2005). Interestingly, hSPCA1
expression is even decreased in the affected areas of DD
skin, showing that epidermal stress induces ATP2A2 and
ATP2C1 downregulation in these disorders, which could not
be observed in other acantholytic dermatoses (Porgpermdee
et al., 2005). This latter observation is in contrast with cell
culture results where an upregulation of SPCA1 was detected
in DD keratinocytes (Foggia et al., 2006).
Both SERCA2 and HSPCA1 are involved in the regulation
of cytoplasmic Ca2þ oscillations upon external stimulation of
the cells (Missiaen et al., 2000; Berridge et al., 2003; Mitchell
et al., 2004). Some studies showed that HHD keratinocytes
possess a higher cytoplasmic resting Ca2þ level (Hu et al.,
2000). Others have failed to detect this increase but
demonstrated it in DD keratinocytes, suggesting that SER-
CA2b has a more prominent role in maintaining resting levels
of cytosolic Ca2þ than hSPCA1 (Leinonen et al., 2005). On
the contrary, a recent report found that DD keratinocytes
rather possess a lower resting cytosolic calcium level, but
show a more robust calcium response than normal controls
(Foggia et al., 2006). Despite the conflicting results, these
studies all demonstrate a disturbed intracellular calcium
regulation in both aberrant cell types compared to normal
keratinocytes. This disturbance likely leads to the decreased
ability of HHD keratinocytes to accumulate Ca2þ in
increasing levels of extracellular Ca2þ concentration com-
pared to wild-type cells (Hu et al., 2000). Observations in a
PMR1-deficient yeast model system suggest that this disability
may be a general consequence of SPCA dysfunction (Szigeti
et al., 2005).
SERCA2 and SPCA1 promote the maintenance of the
ER/Golgi Ca2þ pools that are crucial for proper protein
processing through the secretory pathway. Recent studies
showed an increased expression of SPCA1 in DD keratino-
cytes, arguing for functional overlaps between the two
ATPases at the cellular level (Foggia et al., 2006). Similar
observations have been made earlier in PMR1-defective yeast
cells with regard to other secretory pathway calcium
transporters (Kellermayer et al., 2003). The decreased Ca2þ
content in the secretory pathway pools activates the unfolded
protein response that may lead to apoptosis (Orrenius et al.,
2003), causes disturbances in protein glycosylation, and
leads to defective ER-associated protein degradation (Ramos-
Castaneda et al., 2005). Indeed, the DD-specific corps
ronds resemble apoptotic keratinocytes and inhibition of all
SERCAs in normal keratinocytes impairs the proper trafficking
of desmosomal transmembrane and plaque proteins. Yet,
glycosylation of these proteins is normal in DD keratinocytes
and the desmosomal cadherins are efficiently transported to
the cell surface with the exception of desmoplakin that forms
insoluble aggregates (Dhitavat et al., 2003a). Similarly, small
interfering RNA (where SPCA1 expression decreased close to
undetectable levels) studies indicated that hSPCA1 exerts
significant effects on both Golgi and ER function such as
post-translational glycan processing, ER-associated protein
degradation (ERAD), and response to ER stress that may
alter desmosomal protein processing (Mitchell et al., 2004;
Ramos-Castaneda et al., 2005). However, HHD keratinocytes
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have normal amounts of desmosomal proteins that can bind
other proteins with the same efficiency as seen in normal
epidermal cells. Additionally, desmosome formation and
response to noxious UVB irradiation are also similar in
monolayer HHD and normal keratinocyte cultures (Bernards
and Korge, 2000). These observations indicate that distur-
bances in cellular Ca2þ homeostasis are present in DD and
HHD keratinocytes and significant reduction of SERCA2b
and SPCA1 function can adversely affect desmosomal protein
processing. Yet, direct experiments on DD and HHD
keratinocytes (where protein expression is usually around
50% of normal) failed to detect major disturbances in
desmosomal integrity at the cellular/functional level.
WHY THE SKIN ONLY?
As highlighted earlier, autosomal-dominant Ca2þ ATPase
disorders selectively affect the skin. The reason for this is still
not well understood and is likely complex. Some of the
possible explanations that may collectively lead to this organ
specificity are as follows:
1. As already noted, SERCA2b and hSPCA1 are most
abundantly expressed in keratinocytes and contribute
to cellular Ca2þ homeostasis most prominently in these
cells. Consequently, haploinsufficient expression of the
transporters may affect keratinocytes most severely.
2. Altered intracellular Ca2þ homeostasis may significantly
hamper the processing of desmosomal proteins causing a
failure in proper cell-to-cell adhesion. However, direct
cell culture studies on HHD keratinocytes oppose a
major disturbance in this respect (see above).
3. Exacerbating factors of DD and HHD may affect the skin
most prominently. Indeed, whereas intracellular organs
are mostly protected from physical insults, the skin is
exposed to the environment. Thus, friction, UV radiation,
temperature changes, etc. can most significantly affect the
skin and cause a decrease in the already haploinsufficient
expression of SERCA2 and SPCA1 according to cell culture
and immunohistochemical observations (it should be
noted again that further epidermal studies will be required
to address these aspects of protein expression in vivo).
Consequently, the amount of these two proteins may reach
a critically low level (enough to induce the pathologic
changes of DD and HHD in the epidermis) upon noxious
stimulation of the skin in the affected individuals.
4. Compensatory mechanisms for SERCA2 and SPCA1
deficiency may be less effective in the epidermis.
Although SERCA3 is expressed in most tissues, it is
absent (or very mildly expressed) in keratinocytes. This
may indicate a decreased ability of these cells to
compensate for the partial loss of SERCA2b or hSPCA1
(Martin et al., 2002).
5. The skin may be special with regard to Ca2þ homeostasis
compared to other tissues and organs. Indeed, a unique
Ca2þ gradient is present in the healthy epidermis with
lowest calcium levels in the basal layer and highest in the
granular layer of the skin. This gradient appears to be a
key element for the differentiation process in the
epidermis through a counter-talk between keratinocytes
and the extracellular space in which the calcium sensing
receptor (CaR) is an important player (Tu et al., 2001;
Elias et al., 2002). The epidermal calcium gradient
dissipates upon perturbations in the permeability barrier
of the skin (i.e., noxious stimuli) within minutes and is
restored to normal within 6–24 hours under ideal condi-
tions (Mao-Qiang et al. 1997). During this repair process,
there is a small overshoot where Ca2þ concentrations in
the spinous/suprabasal layers actually increase to a level
slightly higher than the preceding resting level (Menon
et al., 1992; Mauro et al., 1998). This increase may be
critically important as extracellular Ca2þ can directly
reinforce desmosomal connections (O’Keefe et al.,
1987). These processes have been shown to be important
for the skin to optimize recovery following injury
(Grzesiak and Pierschbacher, 1995). The fact that
SERCA2b and hSPCA1 are high-affinity, low-capacity
Ca2þ transporters argues that these pumps serve to
maintain a steady, less releasable Ca2þ pool that has to
be maintained for proper cellular functions rather than
the fast replenishment of releasable Ca2þ pools as
SERCA1 does. Consequently, it is likely that SERCA2b
and hSPCA1 are the most important in building up the
relatively steady epidermal Ca2þ gradient. Indeed, the
epidermal Ca2þ gradient is absent in HHD epidermis
even in the intact areas of the skin. This is likely due
to the inability of HHD keratinocytes to accumulate
calcium properly in the granular layer (Hu et al., 2000).
The absence of the Ca2þ gradient likely leads to the lack
of external Ca2þ increase (that could reinforce desmo-
somal connections directly) in the suprabasal layer
following physical stress. Hence, the desmosomal con-
nections fail to be reinforced leading to the suprabasal
vulnerability of HHD epidermis to noxious stimuli.
Consequently, suprabasal acantholyis may ensue (Kel-
lermayer, 2005). The fact that the rash of HHD can
appear within 1 hour following physical trauma (Burge,
1992) makes it less probable that cellular mechanisms
involving protein expression and transport are the
primary inducers of acantholysis and supports the theory
above. Interestingly, the human epidermal Ca2þ gradient
is more distinct than that of rats and mice (Elias et al.,
1998), which may in part explain the observed pheno-
typic differences between ATP2A2þ / mice and DD
(Prasad et al., 2004, 2005). However, the epidermal
Ca2þ gradient has not been studied in DD yet.
6. Aging and hormones may differentially affect epidermal
ATP2A2 and ATP2C1 expression. The peculiar presentation
of DD and HHD around puberty or even later in life argues
that the aging process and/or hormonal changes signifi-
cantly influence the epidermal role of SERCA2 and SPCA1,
which may not be the case for other tissues and organs.
Possible modes of therapy in DD and HHD
Identification and avoidance of exacerbating factors is the
first step in therapy for both DD and HHD. Furthermore, oral
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and topical retinoids have proved to be quite useful in the
treatment of DD. Topical 5-fluorouracil, tazarotene, and
calcipotriol have also been effective in addition to oral
cyclosporine, contraceptives, and diltiazem. Surgical meth-
ods and laser therapy has been utilized with success also
(Sehgal and Srivastava, 2005). Topical steroids, antibiotics,
and antiseptics have been promoted traditionally for the
treatment of HHD. More recently, FK506 and vitamin D3
analogues have proved to be useful in certain cases and laser
therapy has also been effective (Kruppa et al., 2000; Sand and
Thomsen, 2003; Bianchi et al., 2004; Foggia and Hovnanian,
2004). Despite the significant variety of therapeutic mod-
alities, the treatment of both DD and HHD can be
challenging (Lorentzen and Svejgaard, 2001; Mak et al.,
2005). Consequently, novel approaches should be sought.
We recently proposed that topically applied translational
readthrough-inducing agents may be of significant value for
the therapy of genodermatoses mediated by nonsense
mutations, such as a subset of HHD cases (Kellermayer
et al., 2006).
CONCLUSION
The selective manifestation of DD and HHD in the skin
indicates that both human keratinocytes and the epidermis
hold unique features of Ca2þ regulation where the high-
affinity, low-capacity Ca2þ ATPases play a more prominent
role than in other cells and tissues of the human body. The
lack of significant functional alterations at the cellular level
with respect to growth and cell adhesion in DD and HHD
keratinocytes highlights the potentially pivotal role of epider-
mal Ca2þ homeostasis in the autosomal-dominant Ca2þ
ATPase disorders and proposes that the tissue differentiation of
the skin may be a key element for the epidermal appearance
of these genodermatoses. Additionally, the age-dependent
onset and the significant variability in the expressivity of the
symptoms (even within the same family) argue that epigenetic
factors surpassing the cellular level of regulation greatly
influence the manifestation of DD and HHD. These observa-
tions highlight the importance of future experiments at the
organ (i.e., skin) and organism (i.e., clinical) level for
elucidating the pathogenesis of DD and HHD.
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